Antibiotic Treatment for Acute Bacterial Infections
For acute bacterial infections, initiate short-course antibiotic therapy (3-5 days) with pathogen-specific agents, prioritizing amoxicillin for respiratory infections, nitrofurantoin or TMP-SMZ for uncomplicated UTIs, and amoxicillin-clavulanate for skin infections, with treatment duration guided by clinical response rather than arbitrary extended courses. 1
Treatment Duration: The Shift to Shorter Courses
The most critical evidence-based change in antibiotic management is the move away from prolonged courses:
For community-acquired pneumonia (CAP): A 5-day course is sufficient when patients achieve clinical stability (no fever for 48 hours), with 70% of patients successfully completing treatment at this duration without increased failure rates 1
For uncomplicated cystitis in women: Use nitrofurantoin for 5 days, TMP-SMZ for 3 days, or fosfomycin as a single dose 1
For uncomplicated pyelonephritis: Fluoroquinolones for 5-7 days (not 10 days) or TMP-SMZ for 14 days based on susceptibility 1
For cellulitis (including COPD patients): A 5-day course is recommended, with extension only if infection has not improved 2
For complicated intra-abdominal infections: After adequate source control, 3-5 days of antibiotics produces similar outcomes to longer courses 1
First-Line Antibiotic Selection by Infection Type
Respiratory Tract Infections
Acute Bacterial Sinusitis:
- Delay antibiotics until symptoms persist ≥10 days or worsen after 5-7 days to distinguish bacterial from viral etiology 1
- First-line: Amoxicillin 3g/day for adults 1 or amoxicillin-clavulanate for children 1
- Duration: 10-14 days for sinusitis 1, though shorter courses of newer agents show similar efficacy 1
Community-Acquired Pneumonia:
- Adults without risk factors: Amoxicillin 3g/day orally for suspected pneumococcal infection (especially >40 years) 1
- Adults <40 years without underlying disease: Macrolides for atypical bacterial pneumonia 1
- Children: Amoxicillin 80-100 mg/kg/day in three divided doses for <30 kg 1
- Duration: 10 days for pneumococcal pneumonia, 14 days for atypical pneumonia 1
Acute Bronchitis:
- Do not prescribe antibiotics for acute bronchitis in healthy adults—it is predominantly viral and antibiotics provide no benefit over placebo 1
Pediatric Infections
Acute Bacterial Sinusitis in Children:
- Severe presentation (fever ≥39°C + purulent discharge ≥3 days) or worsening symptoms: Immediate antibiotic therapy 1
- Persistent symptoms (≥10 days): Either antibiotic therapy OR additional 3-day observation period 1
- First-line: Amoxicillin with or without clavulanate 1
Acute Otitis Media:
- Azithromycin: 30 mg/kg as single dose, OR 10 mg/kg daily for 3 days, OR 10 mg/kg day 1 then 5 mg/kg days 2-5 3
- Number needed to treat is 3-5 for persistent symptoms 1
Urinary Tract Infections
Uncomplicated Cystitis (Women):
- Nitrofurantoin 5 days, TMP-SMZ 3 days, or fosfomycin single dose 1
- Avoid fluoroquinolones empirically due to adverse effect profile; reserve for resistant organisms 1
Uncomplicated Pyelonephritis:
- Fluoroquinolones 5-7 days (not 10 days) OR TMP-SMZ 14 days based on susceptibility 1
- Clinical cure rates exceed 93% with 5-day fluoroquinolone courses 1
Skin and Soft Tissue Infections
Cellulitis:
- 5-day course with extension only if no improvement 2
- Mild-moderate: Clindamycin 300-450 mg orally four times daily for 5 days (especially for penicillin allergies) 2
- Alternative: Amoxicillin-clavulanate for dual coverage of respiratory and skin pathogens 2
- Add MRSA coverage (TMP-SMZ or clindamycin) only with specific risk factors 2
- Adjunctive measure: Elevate affected area to promote drainage 2
Critical Assessment Points
Evaluate treatment response at 48-72 hours:
- For sinusitis: Symptoms should decrease within this timeframe; do not change antibiotics before 72 hours unless clinical worsening 1
- For cellulitis: Assess within 3-4 days; if no improvement by 5 days, extend therapy and reassess for alternative causes rather than defaulting to longer treatment 2
- For pneumonia: Clinical stability criteria include no fever for 48 hours 1
When to extend beyond short-course therapy:
- Patients with ongoing signs of infection beyond 5-7 days warrant diagnostic investigation for uncontrolled source or treatment failure 1
- Each additional day of antibiotics carries 5% increased risk of adverse events without added benefit 1
Common Pitfalls to Avoid
Do not treat viral infections with antibiotics:
- Acute bronchitis in healthy adults is viral; antibiotics provide no benefit 1
- Purulent sputum during acute bronchitis does not indicate bacterial superinfection 1
Do not use antibiotics for dental infections without surgical intervention:
- For acute dental abscesses, treatment is surgical only (root canal or extraction) 1
- For acute dentoalveolar abscesses, perform incision and drainage first, then amoxicillin for 5 days 1
Avoid unnecessary broad-spectrum coverage:
- Start with narrow-spectrum agents and de-escalate once organism identified 4
- Combination therapy is not more effective than monotherapy in most ICU trials 4
Do not prescribe antibiotics for uncomplicated acute bacterial sinusitis before 10 days: